Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cognizant Technology Solutions (NQ:CTSH)

74.43 -0.48 (-0.64%)
Streaming Delayed Price Updated: 11:11 AM EDT, Jul 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cognizant Technology Solutions

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Looking Into Cognizant Tech Solns's Recent Short Interest
 
Via Benzinga
$100 Invested In Cognizant Tech Solns 20 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Market Analysis: Cognizant Tech Solns And Competitors In IT Services Industry
 
Via Benzinga
AI revolution: 3 stocks set to soar as technology evolves
As AI stocks surge, Accenture expects investment in AI, creating opportunities for market leaders. Cognizant, Snowflake and Salesforce are undervalued AI names. 
Via MarketBeat
Topics Artificial Intelligence
10 Surprising Artificial Intelligence (AI) Stocks You Should Consider
Explore how AI is reshaping unexpected industries and transforming the investment landscape before your eyes. 
Via The Motley Fool
Topics Artificial Intelligence
$100 Invested In This Stock 15 Years Ago Would Be Worth $800 Today
 
Via Benzinga
Exploring The Competitive Space: Cognizant Tech Solns Versus Industry Peers In IT Services
 
Via Benzinga
(CTSH) - Analyzing Cognizant Tech Solns's Short Interest
 
Via Benzinga
P/E Ratio Insights for Cognizant Tech Solns
 
Via Benzinga
FCCI Insurance Group Chooses Cloud-Based Technology, Duck Creek OnDemand, and Duck Creek Policy to Enhance Underwriting Ease and Expand Capabilities
With seamless upgrades through Duck Creek’s Active Delivery, FCCI can capitalize on market expansion, foster innovation, and improve customer experiences 
From Duck Creek Technologies
Via GlobeNewswire
Expert Ratings for Cognizant Tech Solns
 
Via Benzinga
Morgan Stanley Maintains Equal-Weight Rating for Cognizant Tech Solns: Here's What You Need To Know
 
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,100 Today
 
Via Benzinga
Analyst Ratings for Cognizant Tech Solns
 
Via Benzinga
Peering Into Cognizant Tech Solns's Recent Short Interest
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023
 
Via Benzinga
Union Pacific To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page 
Via Benzinga
$1000 Invested In Cognizant Tech Solns 20 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Peering Into Cognizant Tech Solns's Recent Short Interest
 
Via Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $13,000 Today
 
Via Benzinga
How Is The Market Feeling About Cognizant Tech Solns?
 
Via Benzinga
Infosys Earnings Meet Estimates, Stock Falls On Weak Revenue Outlook
Infosys reported fiscal Q2 profit that met views while revenue edged by estimates. INFY stock fell on weak fiscal 2024 revenue guidance. 
Via Investor's Business Daily
Here's How Much You Would Have Made Owning Cognizant Tech Solns Stock In The Last 15 Years
 
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $500 Today
 
Via Benzinga
Looking Into Cognizant Tech Solns's Recent Short Interest
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023
 
Via Benzinga
7 Analysts Have This to Say About Cognizant Tech Solns
 
Via Benzinga
Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor
 
Via Benzinga
Topics Artificial Intelligence
Here's How Much $100 Invested In Cognizant Tech Solns 20 Years Ago Would Be Worth Today
 
Via Benzinga
Google Parent Alphabet's Stock Top Stories: AFP's Lawsuit Against Elon Musk's X and Alphabet's AI Healthcare Venture
In today's top stories related to Alphabet Inc. (NASDAQ: GOOG), we delve into regulatory challenges and a promising partnership in the healthcare sector. Regulatory Hurdles: 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.